Summary

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Drug-Device Combination Products market size will reach 46,806 Million USD in 2026 and is projected to reach 74,719 Million USD by 2033, with a CAGR of 6.91% (2026-2033). Notably, the China Drug-Device Combination Products market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Drug-device combination products are specialized medical products that combine a pharmaceutical drug with a medical device in a single package or system. These products are designed to work together to provide a specific therapeutic effect or treatment approach. Examples include inhalers that deliver medication directly to the lungs, insulin pens that facilitate the administration of insulin, and transdermal patches that deliver drugs through the skin. These combination products often offer enhanced convenience, improved drug delivery accuracy, and better patient compliance compared to using drugs or devices separately. Their development and regulation involve considerations from both the pharmaceutical and medical device industries, ensuring safety, efficacy, and proper functionality of the combined components.

The major global suppliers of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Medtronic, Boehringer Ingelheim, Mylan, 3M, Smith & Nephew, Hisamitsu, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Drug-Device Combination Products. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Drug-Device Combination Products market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug-Device Combination Products market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug-Device Combination Products industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Drug-Device Combination Products Include:

GSK

Novo Nordisk

Eli Lilly

AstraZeneca

Sanofi

Boston Scientific

Abbott

Medtronic

Boehringer Ingelheim

Mylan

3M

Smith & Nephew

Hisamitsu

Molnlycke

Teleflex

BD

Lepu Medical

MicroPort

Terumo

B. Braun

Antares Pharma

Drug-Device Combination Products Product Segment Include:

Drug-Coated Device

Prefilled Drug Delivery Systems

Nebulizer and Inhaler

Transdermal Delivery System

Others

Drug-Device Combination Products Product Application Include:

Hospital and Clinic

Retail Pharmacies

Other




Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drug-Device Combination Products Industry PESTEL Analysis

Chapter 3: Global Drug-Device Combination Products Industry Porter’s Five Forces Analysis

Chapter 4: Global Drug-Device Combination Products Major Regional Market Size and Forecast Analysis

Chapter 5: Global Drug-Device Combination Products Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drug-Device Combination Products Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

ページTOPに戻る

Table of Contents

Table of Contents

1 Drug-Device Combination Products Market Overview

  1.1 Product Definition and Statistical Scope

   1.2 Drug-Device Combination Products Product by Type

       1.2.1 Drug-Coated Device

       1.2.2 Prefilled Drug Delivery Systems

       1.2.3 Nebulizer and Inhaler

       1.2.4 Transdermal Delivery System

       1.2.5 Others

   1.3 Drug-Device Combination Products Product by Application

       1.3.1 Hospital and Clinic

       1.3.2 Retail Pharmacies

       1.3.3 Other

   1.4 Global Drug-Device Combination Products Market Size Analysis (2021-2033)

   1.5 Drug-Device Combination Products Market Development Status and Trends

       1.5.1 Drug-Device Combination Products Industry Development Status Analysis

       1.5.2 Drug-Device Combination Products Industry Development Trends Analysis

2 Drug-Device Combination Products Market PESTEL Analysis

   2.1 Political Factors Analysis

   2.2 Economic Factors Analysis

   2.3 Social Factors Analysis

   2.4 Technological Factors Analysis

   2.5 Environmental Factors Analysis

   2.6 Legal Factors Analysis

3 Drug-Device Combination Products Market Porter's Five Forces Analysis

   3.1 Competitive Rivalry

   3.2 Threat of New Entrants

   3.3 Bargaining Power of Suppliers

   3.4 Bargaining Power of Buyers

   3.5 Threat of Substitutes

4 Global Drug-Device Combination Products Market Analysis by Regions

   4.1 Drug-Device Combination Products Overall Market: 2025 VS 2026 VS 2033

   4.2 Global Drug-Device Combination Products Revenue and Forecast Analysis (2021-2033)

       4.2.1 Global Drug-Device Combination Products Revenue and Market Share by Region (2021-2026)

       4.2.2 Global Drug-Device Combination Products Revenue and Market Share Forecast by Region (2027-2033)

5 Global Drug-Device Combination Products Market Size by Type and Application

   5.1 Global Drug-Device Combination Products Market Size by Type (2021-2033)

   5.2 Global Drug-Device Combination Products Market Size by Application (2021-2033)

6 North America

   6.1 North America Drug-Device Combination Products Market Size and Growth Rate Analysis (2021-2033)

   6.2 North America Key Suppliers Analysis

   6.3 North America Drug-Device Combination Products Market Size by Type

   6.4 North America Drug-Device Combination Products Market Size by Application

   6.5 North America Drug-Device Combination Products Market Size by Country

       6.5.1 US

       6.5.2 Canada

7 Europe

   7.1 Europe Drug-Device Combination Products Market Size and Growth Rate Analysis (2021-2033)

   7.2 Europe Key Suppliers Analysis

   7.3 Europe Drug-Device Combination Products Market Size by Type

   7.4 Europe Drug-Device Combination Products Market Size by Application

   7.5 Europe Drug-Device Combination Products Market Size by Country

       7.5.1 Germany

       7.5.2 France

       7.5.3 United Kingdom

       7.5.4 Italy

       7.5.5 Spain

       7.5.6 Benelux

8 China

   8.1 China Drug-Device Combination Products Market Size and Growth Rate Analysis (2021-2033)

   8.2 China Key Suppliers Analysis

   8.3 China Drug-Device Combination Products Market Size by Type

   8.4 China Drug-Device Combination Products Market Size by Application

9 APAC (excl. China)

   9.1 APAC (excl. China) Drug-Device Combination Products Market Size and Growth Rate Analysis (2021-2033)

   9.2 APAC (excl. China) Key Suppliers Analysis

   9.3 APAC (excl. China) Drug-Device Combination Products Market Size by Type

   9.4 APAC (excl. China) Drug-Device Combination Products Market Size by Application

   9.5 APAC (excl. China) Drug-Device Combination Products Market Size by Country

       9.5.1 Japan

       9.5.2 South Korea

       9.5.3 India

       9.5.4 Australia

       9.5.5 Southeast Asia

10 Latin America

   10.1 Latin America Drug-Device Combination Products Market Size and Growth Rate Analysis (2021-2033)

   10.2 Latin America Key Suppliers Analysis

   10.3 Latin America Drug-Device Combination Products Market Size by Type

   10.4 Latin America Drug-Device Combination Products Market Size by Application

   10.5 Latin America Drug-Device Combination Products Market Size by Country

       10.5.1 Mexico

       10.5.2 Brazil

11 Middle East & Africa

   11.1 Middle East & Africa Drug-Device Combination Products Market Size and Growth Rate Analysis (2021-2033)

   11.2 Middle East & Africa Key Suppliers Analysis

   11.3 Middle East & Africa Drug-Device Combination Products Market Size by Type

   11.4 Middle East & Africa Drug-Device Combination Products Market Size by Application

   11.5 Middle East & Africa Drug-Device Combination Products Market Size by Country

       11.5.1 Saudi Arabia

       11.5.2 South Africa

12 Competition by Suppliers

   12.1 Global Drug-Device Combination Products Market Revenue by Key Suppliers (2021-2033)

   12.2 Drug-Device Combination Products Competitive Landscape Analysis and Market Dynamic

       12.2.1 Drug-Device Combination Products Competitive Landscape Analysis

       12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales

       12.2.3 Market Dynamic

13 Key Companies Analysis

   13.1 GSK

       13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.1.2 GSK Drug-Device Combination Products Product Portfolio

       13.1.3 GSK Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.2 Novo Nordisk

       13.2.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.2.2 Novo Nordisk Drug-Device Combination Products Product Portfolio

       13.2.3 Novo Nordisk Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.3 Eli Lilly

       13.3.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.3.2 Eli Lilly Drug-Device Combination Products Product Portfolio

       13.3.3 Eli Lilly Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.4 AstraZeneca

       13.4.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.4.2 AstraZeneca Drug-Device Combination Products Product Portfolio

       13.4.3 AstraZeneca Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.5 Sanofi

       13.5.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.5.2 Sanofi Drug-Device Combination Products Product Portfolio

       13.5.3 Sanofi Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.6 Boston Scientific

       13.6.1 Boston Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.6.2 Boston Scientific Drug-Device Combination Products Product Portfolio

       13.6.3 Boston Scientific Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.7 Abbott

       13.7.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.7.2 Abbott Drug-Device Combination Products Product Portfolio

       13.7.3 Abbott Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.8 Medtronic

       13.8.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.8.2 Medtronic Drug-Device Combination Products Product Portfolio

       13.8.3 Medtronic Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.9 Boehringer Ingelheim

       13.9.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.9.2 Boehringer Ingelheim Drug-Device Combination Products Product Portfolio

       13.9.3 Boehringer Ingelheim Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.10 Mylan

       13.10.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.10.2 Mylan Drug-Device Combination Products Product Portfolio

       13.10.3 Mylan Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.11 3M

       13.11.1 3M Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.11.2 3M Drug-Device Combination Products Product Portfolio

       13.11.3 3M Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.12 Smith & Nephew

       13.12.1 Smith & Nephew Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.12.2 Smith & Nephew Drug-Device Combination Products Product Portfolio

       13.12.3 Smith & Nephew Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.13 Hisamitsu

       13.13.1 Hisamitsu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.13.2 Hisamitsu Drug-Device Combination Products Product Portfolio

       13.13.3 Hisamitsu Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.14 Molnlycke

       13.14.1 Molnlycke Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.14.2 Molnlycke Drug-Device Combination Products Product Portfolio

       13.14.3 Molnlycke Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.15 Teleflex

       13.15.1 Teleflex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.15.2 Teleflex Drug-Device Combination Products Product Portfolio

       13.15.3 Teleflex Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.16 BD

       13.16.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.16.2 BD Drug-Device Combination Products Product Portfolio

       13.16.3 BD Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.17 Lepu Medical

       13.17.1 Lepu Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.17.2 Lepu Medical Drug-Device Combination Products Product Portfolio

       13.17.3 Lepu Medical Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.18 MicroPort

       13.18.1 MicroPort Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.18.2 MicroPort Drug-Device Combination Products Product Portfolio

       13.18.3 MicroPort Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.19 Terumo

       13.19.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.19.2 Terumo Drug-Device Combination Products Product Portfolio

       13.19.3 Terumo Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.20 B. Braun

       13.20.1 B. Braun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.20.2 B. Braun Drug-Device Combination Products Product Portfolio

       13.20.3 B. Braun Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.21 Antares Pharma

       13.21.1 Antares Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.21.2 Antares Pharma Drug-Device Combination Products Product Portfolio

       13.21.3 Antares Pharma Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

   14.1 Drug-Device Combination Products Industry Chain Analysis

   14.2 Drug-Device Combination Products Typical Downstream Customers

   14.3 Drug-Device Combination Products Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

   16.1 Methodology/Research Approach

   16.2 Research Scope

   16.3 Benchmarks and Assumptions

   16.4 Date Source

       16.4.1 Primary Sources

       16.4.2 Secondary Sources

   16.5 Data Cross Validation

   16.6 Disclaimer